The promise of chimeric antigen receptor T cells (CARTs) in leukaemia

被引：19
作者：
Orlowski, Robert J. [1 ]
Porter, David L. [1 ]
Frey, Noelle V. [1 ]
机构：
[1] Univ Penn, Dept Hematol Oncol, Philadelphia, PA USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 01期
关键词：
chimeric antigen receptor T cells; immunotherapy; leukaemia; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CYTOKINE RELEASE SYNDROME; B-CELL; ADOPTIVE IMMUNOTHERAPY; CANCER-IMMUNOTHERAPY; ENHANCED SURVIVAL; PROGNOSTIC INDEX; PD-1; BLOCKADE; CD19;
D O I：
10.1111/bjh.14475
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The success of genetically engineered T cells that express chimeric antigen receptors ( CARTs) has been a momentous step forward in harnessing the potent cancer fighting abilities of the immune system. The efficacy seen in relapsed/refractory ( r/r) acute lymphoblastic leukaemia ( ALL), not only by inducing remission, but also in maintaining long-term disease control, has been unprecedented. While the foundation for this approach has been firmly set in place, continued development will improve the efficacy, toxicity and applicability to other malignancies of this new class of 'living drugs'. In this review, we provide a comprehensive overview of the most current clinical trial data in both acute and chronic leukaemias, and discuss some of the potential ways to enhance the activity and safety of CART therapy going forward.
引用
收藏
页码：13 / 26
页数：14
相关论文
共 94 条
[31]   Acute Lymphoblastic Leukemia in Children [J].
Hunger, Stephen P. ;
Mullighan, Charles G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16) :1541-1552
[32]   Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group [J].
Hunger, Stephen P. ;
Lu, Xiaomin ;
Devidas, Meenakshi ;
Camitta, Bruce M. ;
Gaynon, Paul S. ;
Winick, Naomi J. ;
Reaman, Gregory H. ;
Carroll, William L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) :1663-1669
[33]   Remote Control of Therapeutic T Cells Through a Small Molecule-Gated Chimeric Receptor [J].
Issa, Fadi .
TRANSPLANTATION, 2015, 99 (12) :2434-2434
[34]   CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity [J].
Jacoby, Elad ;
Nguyen, Sang M. ;
Fountaine, Thomas J. ;
Welp, Kathryn ;
Gryder, Berkley ;
Qin, Haiying ;
Yang, Yinmeng ;
Chien, Christopher D. ;
Seif, Alix E. ;
Lei, Haiyan ;
Song, Young K. ;
Khan, Javed ;
Lee, Daniel W. ;
Mackall, Crystal L. ;
Gardner, Rebecca A. ;
Jensen, Michael C. ;
Shern, Jack F. ;
Fry, Terry J. .
NATURE COMMUNICATIONS, 2016, 7
[35]   Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CDI9-Specific Chimeric Antigen Receptor Redirected T Cells in Humans [J].
Jensen, Michael C. ;
Popplewell, Leslie ;
Cooper, Laurence J. ;
DiGiusto, David ;
Kalos, Michael ;
Ostberg, Julie R. ;
Forman, Stephen J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) :1245-1256
[36]   The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells [J].
Jordan, CT ;
Upchurch, D ;
Szilvassy, SJ ;
Guzman, ML ;
Howard, DS ;
Pettigrew, AL ;
Meyerrose, T ;
Rossi, R ;
Grimes, B ;
Rizzieri, DA ;
Luger, SM ;
Phillips, GL .
LEUKEMIA, 2000, 14 (10) :1777-1784
[37]   T cell exclusion, immune privilege, and the tumor microenvironment [J].
Joyce, Johanna A. ;
Fearon, Douglas T. .
SCIENCE, 2015, 348 (6230) :74-80
[38]   Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology [J].
Kalos, Michael ;
June, Carl H. .
IMMUNITY, 2013, 39 (01) :49-60
[39]   T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia [J].
Kalos, Michael ;
Levine, Bruce L. ;
Porter, David L. ;
Katz, Sharyn ;
Grupp, Stephan A. ;
Bagg, Adam ;
June, Carl H. .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (95)
[40]  
Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI [10.1016/j.immuni.2016.01.021, 10.1016/j.immuni.2016.02.023]
12345678910